Vincenzo Carafa
Ariano Irpino-martiri, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Lysine demethylase (KDM) inhibitors for the treatment of cancer: a patent review (2015-present).
Journal: Expert opinion on therapeutic patents
Published: December 10, 2025
Nutritional Regulation of Cardiac Metabolism and Function: Molecular and Epigenetic Mechanisms and Their Role in Cardiovascular Disease Prevention.
Journal: Nutrients
Published: November 28, 2025
Dynamic epigenetic regulation of BCLAF1 splicing in acute myeloid leukemia.
Journal: Cell death & disease
Published: October 30, 2025
UVI5008: the first reversible, non-covalent Bruton's tyrosine kinase epi-inhibitor for B-cell malignancies.
Journal: Journal of hematology & oncology
Published: October 27, 2025
Glycolytic heterogeneity drives metabolic-targeted therapy in pancreatic ductal adenocarcinoma.
Journal: Signal transduction and targeted therapy
Published: July 28, 2025
Editor's Note: c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 12, 2025
Editor's Note: RIP1-HAT1-SIRT Complex Identification and Targeting in Treatment and Prevention of Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 12, 2025
Unravelling the impact of the chromobox proteins in human cancers.
Journal: Cell death & disease
Published: December 09, 2024
"Aging and epigenetic implications in radiotherapy: The promise of BNCT".
Journal: Ageing research reviews
Published: November 21, 2024
Corrigendum to "Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities" [Int. J. Biochem. Cell Biol. 39(10) (2007) 1902-1914].
Journal: The international journal of biochemistry & cell biology
Published: July 16, 2024
METTL16-mediated inhibition of MXD4 promotes leukemia through activation of the MYC-MAX axis.
Journal: Oncogene
Published: July 01, 2024
Inverse FASN and LDHA correlation drives metabolic resistance in breast cancer.
Journal: Journal of translational medicine
Published: June 12, 2024
Last Updated: 09/26/2026